申请人:MAX PLANCK GESELLSCHAFT
公开号:WO2003015772A1
公开(公告)日:2003-02-27
Compounds of formula I, wherein R?1, R2, R3, R4 and R5¿ have the meanings as given in claim 1, and their pharmaceutically tolerable derivatives, solvates and stereoisomers and their use for the preparation of a pharmaceutical for inhibiting the formation of polyQ-aggregation.